Skip to Main Content

1,373

Views

3

CrossRef citations to date

0

Altmetric

Original Article

Efficacy and safety of sirukumab in Japanese patients with active rheumatoid arthritis who were refractory or intolerant to anti-tumor necrosis factor therapy: Subgroup analysis of a randomized, double-blind, multicenter, phase 3 study (SIRROUND-T)

Yoshiya TanakaFirst Department of Internal Medicine, School of Medicine, University of Occupational & Environmental Health Japan, Kitakyushu, Japan; View further author information

,

Tsutomu TakeuchiDivision of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan; View further author information

,

Masayoshi HarigaiDepartment of Epidemiology and Pharmacoepidemiology, Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan; View further author information

,

Hisashi YamanakaInstitute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan; View further author information

,

Toshikazu NakanoJanssen Pharmaceutical K.K., Tokyo, Japan; View further author information

,

Koshiro AkagiJanssen Pharmaceutical K.K., Tokyo, Japan; View further author information

,

Yoshifumi UkyoJanssen Pharmaceutical K.K., Tokyo, Japan; View further author information

&

Benjamin HsuJanssen Research & Development, LLC, Spring House, PA, USACorrespondence[email protected]

http://orcid.org/0000-0002-0718-213X View further author information